Okuda T - Search Results

1

Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus.

Ozawa T, Jin A, Tajiri K, Takemoto M, Okuda T, Shiraki K, Kishi H, Muraguchi A. Ozawa T, et al. Among authors: okuda t. Antiviral Res. 2011 Sep;91(3):283-7. doi: 10.1016/j.antiviral.2011.06.012. Epub 2011 Jun 25. Antiviral Res. 2011. PMID: 21726583

2

Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.

Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K. Hasegawa T, et al. Among authors: okuda t. J Med Virol. 2001 Jan;63(1):57-63. J Med Virol. 2001. PMID: 11130888

3

Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.

Honda M, Okuda T, Hasegawa T, Kurokawa M, Shiraki K, Matsuo K, Komatsuzaki M, Niimura M. Honda M, et al. Among authors: okuda t. Antivir Chem Chemother. 2001 Jul;12(4):233-9. doi: 10.1177/095632020101200404. Antivir Chem Chemother. 2001. PMID: 11771732 Free article.

4

Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.

Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K. Okuda T, et al. J Med Virol. 2004 Jan;72(1):112-20. doi: 10.1002/jmv.10562. J Med Virol. 2004. PMID: 14635018

5

Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.

Suzuki M, Okuda T, Shiraki K. Suzuki M, et al. Among authors: okuda t. Antiviral Res. 2006 Nov;72(2):157-61. doi: 10.1016/j.antiviral.2006.05.001. Epub 2006 May 30. Antiviral Res. 2006. PMID: 16797734

6

Design and synthesis of isonucleosides constructed on a 2-oxa-6-thiabicyclo[3.2.0]heptane scaffold.

Yoshimura Y, Asami K, Imamichi T, Okuda T, Shiraki K, Takahata H. Yoshimura Y, et al. Among authors: okuda t. J Org Chem. 2010 Jun 18;75(12):4161-71. doi: 10.1021/jo100556u. J Org Chem. 2010. PMID: 20499939

7

Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.

Himaki T, Masui Y, Chono K, Daikoku T, Takemoto M, Haixia B, Okuda T, Suzuki H, Shiraki K. Himaki T, et al. Among authors: okuda t. Antiviral Res. 2012 Feb;93(2):301-304. doi: 10.1016/j.antiviral.2011.11.015. Epub 2011 Dec 4. Antiviral Res. 2012. PMID: 22155691

8

Characterization of susceptibility variants of influenza virus grown in the presence of T-705.

Daikoku T, Yoshida Y, Okuda T, Shiraki K. Daikoku T, et al. Among authors: okuda t. J Pharmacol Sci. 2014;126(3):281-4. doi: 10.1254/jphs.14156sc. Epub 2014 Oct 9. J Pharmacol Sci. 2014. PMID: 25296868 Free article.

9

Identification of ribonucleotide reductase mutation causing temperature-sensitivity of herpes simplex virus isolates from whitlow by deep sequencing.

Daikoku T, Oyama Y, Yajima M, Sekizuka T, Kuroda M, Shimada Y, Takehara K, Miwa N, Okuda T, Sata T, Shiraki K. Daikoku T, et al. Among authors: okuda t. Clin Case Rep. 2015 Jun;3(6):461-7. doi: 10.1002/ccr3.270. Epub 2015 Apr 22. Clin Case Rep. 2015. PMID: 26185649 Free PMC article.

10

Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.

Daikoku T, Tannai H, Honda M, Onoe T, Matsuo K, Onoye Y, Nishizawa M, Kawana T, Okuda T, Hasegawa T, Shiraki K. Daikoku T, et al. Among authors: okuda t. J Dermatol Sci. 2016 Jun;82(3):160-5. doi: 10.1016/j.jdermsci.2016.02.006. Epub 2016 Feb 15. J Dermatol Sci. 2016. PMID: 26917345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,554 results

Search Page

Filters